Anti-Thymocyte Globulin Prophylaxis in Patients With Hematological Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: An Updated Meta-Analysis

BACKGROUND: Anti-thymocyte globulin (ATG) prophylaxis reduces graft-versus-host disease (GVHD) incidence. This meta-analysis aimed to explore the long-term efficacy of ATG and the influencing factors in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). METHODS: PubM...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xue, Li, Dongjun, Xie, Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417733/
https://www.ncbi.nlm.nih.gov/pubmed/34490116
http://dx.doi.org/10.3389/fonc.2021.717678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417733/
https://www.ncbi.nlm.nih.gov/pubmed/34490116
http://dx.doi.org/10.3389/fonc.2021.717678

Ejemplares similares